Showing results (131-140 of 863) with videos related to
Sort By:
Pageof 87
Haematologica|March 7, 2024
Next-generation strategies to improve safety and efficacy of adeno-associated virus-based gene therapy for hemophilia: lessons from clinical trials in other gene therapiesGiovanni Di Minno, Wolfgang Miesbach, Giancarlo Castaman, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 22, 2022
Management of haemophilia A with inhibitors: A regional cross-talkFlora Peyvandi, Kaan Kavakli, Amal El-Beshlawy, et al.Seminars in Thrombosis and Hemostasis|December 26, 2025
Von Willebrand disease type 2A: an updateOmid Seidizadeh, Luciano Baronciani, Pier Mannuccio Mannucci, et al.Internal and Emergency Medicine|September 1, 2006
Clinical and laboratory patterns of the haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in southern IranMehran Karimi, Ameneh Sabzi, Flora Peyvandi, et al.Seminars in Thrombosis and Hemostasis|July 15, 2009
Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and managementFlora Peyvandi, Roberta Palla, Marzia Menegatti, et al.Blood Transfusion = Trasfusione Del Sangue|February 16, 2023
Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleedingSamantha Pasca, Ezio Zanon, Pier Mannuccio Mannucci, et al.Journal of Thrombosis and Haemostasis : JTH|July 13, 2025
Effects of milvexian alone or with heparin on catheter-induced clotting and thrombin generationRuiqi Yin, James C Fredenburgh, Jeffrey I WeitzThrombosis and Haemostasis|December 8, 2009
Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysisXufang Bai, Jeffrey I Weitz, Peter L GrossChest|July 24, 2008
New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Jeffrey I Weitz, Jack Hirsh, Meyer M SamamaPageof 87